Dr Anish Shah

FDA Approves HEPZATO KIT for Uveal Melanoma with Unresectable Hepatic Metastases

By Dr. Anish Shah Bronx-Lebanon Hospital   On August 14, 2023, the U.S. Food and Drug Administration approved HEPZATO KIT…

9 months ago

FDA Approves Elranatamab-bcmm for Multiple Myeloma with Relapsed or Refractory Status

By Dr. Anish Shah Bronx-Lebanon Hospital   On August 14, 2023, the U.S. Food and Drug Administration granted accelerated approval…

9 months ago

FDA approves niraparib and abiraterone acetate plus prednisone for metastatic prostate cancer With BRCA Mutation

By Dr. Anish Shah Bronx Lebanon Hospital   On August 11, 2023, the U.S. Food and Drug Administration granted regular…

9 months ago

FDA Approves Talquetamab-Tgvs For Adults with Relapsed Or Refractory Multiple Myeloma Patients with at least Four Prior Lines of Therapy

By Dr. Anish Shah Bronx Lebanon Hospital   On August 9, 2023, the U.S. Food and Drug Administration approved talquetamab-tgvs…

9 months ago